Nuveen’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.52M Sell
150,123
-3,392
-2% -$60.7K ﹤0.01% 2183
2025
Q4
$2.46M Sell
153,515
-1,891
-1% -$28.1K ﹤0.01% 2197
2025
Q3
$1.92M Buy
155,406
+7,022
+5% +$82.3K ﹤0.01% 2312
2025
Q2
$1.71M Sell
148,384
-23,252
-14% -$276K ﹤0.01% 2374
2025
Q1
$2.57M Buy
171,636
+41,617
+32% +$697K ﹤0.01% 2232
2024
Q4
$2.25M Sell
130,019
-7,822
-6% -$151K ﹤0.01% 2339
2024
Q3
$2.55M Hold
137,841
﹤0.01% 2299
2024
Q2
$2.8M Hold
137,841
﹤0.01% 2217
2024
Q1
$2.35M Buy
137,841
+2,938
+2% +$46.2K ﹤0.01% 2327
2023
Q4
$2.38M Sell
134,903
-6,668
-5% -$134K ﹤0.01% 2331
2023
Q3
$3.4M Buy
141,571
+6,134
+5% +$151K ﹤0.01% 2057
2023
Q2
$3.15M Buy
+135,437
New +$3.06M ﹤0.01% 2137
2023
Q1
Sell
-19,902
Closed -$403K 3121
2022
Q4
$403K Sell
19,902
-31,023
-61% -$601K ﹤0.01% 2933
2022
Q3
$686K Sell
50,925
-1,964
-4% -$33.1K ﹤0.01% 2877
2022
Q2
$1.05M Sell
52,889
-3,306
-6% -$87.8K ﹤0.01% 2756
2022
Q1
$1.65M Buy
56,195
+6,970
+14% +$195K ﹤0.01% 2600
2021
Q4
$1.1M Buy
49,225
+2,288
+5% +$59.7K ﹤0.01% 2830
2021
Q3
$1.3M Sell
46,937
-28,240
-38% -$860K ﹤0.01% 2873
2021
Q2
$2.93M Buy
75,177
+44,041
+141% +$1.58M ﹤0.01% 2532
2021
Q1
$896K Buy
31,136
+7,308
+31% +$250K ﹤0.01% 2925
2020
Q4
$632K Buy
23,828
+1,764
+8% +$36K ﹤0.01% 2971
2020
Q3
$337K Buy
22,064
+2,087
+10% +$43.8K ﹤0.01% 3056
2020
Q2
$406K Buy
19,977
+9,728
+95% +$174K ﹤0.01% 2971
2020
Q1
$106K Sell
10,249
-504,182
-98% -$14.1M ﹤0.01% 3062
2019
Q4
$19.4M Buy
514,431
+508,738
+8,936% +$22.9M 0.01% 1187
2019
Q3
$265K Buy
5,693
+1,080
+23% +$50.2K ﹤0.01% 3068
2019
Q2
$241K Buy
+4,613
New +$271K ﹤0.01% 3157
2014
Q4
Sell
-188
Closed -$28K 1622
2014
Q3
$28K Buy
+188
New +$29K ﹤0.01% 1575
2014
Q2
Sell
-60,838
Closed -$12.1M 1606
2014
Q1
$12.1M Sell
60,838
-730
-1% -$138K 0.07% 323
2013
Q4
$11.8M Sell
61,568
-4,385
-7% -$816K 0.08% 322
2013
Q3
$11.2M Buy
+65,953
New +$10.2M 0.07% 329

Other funds holding CLB